Stockreport

Daiichi Sankyo Is Not A Buy Now [Seeking Alpha]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF Daiichi Sankyo ( OTCPK:DSNKY The prospect to which I refer is the DS-8201 drug, marketed under the brand name Enhertu, which targets HER2 metastatic breast cancer cells. [Read more]